EGFR and breast cancer: Specifically, when detecting epidermal growth factor receptor (EGFR) gene mutations in breast cancer, ddPCR was capable of identifying mutations with an abundance as low as 0.1%, whereas qPCR could only detect mutations at a minimum abundance of 1% in plasmids [26].